Ignite Creation Date:
2025-12-24 @ 11:06 PM
Ignite Modification Date:
2025-12-30 @ 1:32 PM
Study NCT ID:
NCT04162769
Status:
COMPLETED
Last Update Posted:
2022-11-04
First Post:
2019-11-12
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Assess the Safety and Efficacy of Etrasimod in Subjects With Moderate-to-Severe Atopic Dermatitis
Sponsor:
Arena Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-10-04
Start Date Type:
ACTUAL
Primary Completion Date:
2020-09-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-10-11
Completion Date Type:
ACTUAL
First Submit Date:
2019-11-12
First Submit QC Date:
None
Study First Post Date:
2019-11-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-08-24
Results First Submit QC Date:
None
Results First Post Date:
2022-11-04
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2022-11-04
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2022-10-10
Last Update Post Date:
2022-11-04
Last Update Post Date Type:
ACTUAL